Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
10.36
-0.27 (-2.54%)
At close: Oct 17, 2025, 4:00 PM EDT
10.56
+0.20 (1.93%)
After-hours: Oct 17, 2025, 5:39 PM EDT
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $1.26 billion as of October 17, 2025. Its market cap has increased by 444.81% in one year.
Market Cap
1.26B
Enterprise Value
1.06B
1-Year Change
444.81%
Ranking
Category
Stock Price
$10.36
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $1.26B, an increase of 1,384.44%. That is a compound annual growth rate of 51.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 1.26B | 242.65% |
| Dec 31, 2024 | 368.19M | 330.28% |
| Dec 29, 2023 | 85.57M | -26.01% |
| Dec 30, 2022 | 115.65M | 472.04% |
| Dec 31, 2021 | 20.22M | -54.55% |
| Dec 31, 2020 | 44.48M | -33.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |